Trials / Completed
CompletedNCT04258085
Promoting Earlier Detection of Breast Cancer in Rwanda: Scaleup in the National Health Care System
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17,379 (actual)
- Sponsor
- Brigham and Women's Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This observational study evaluates scale-up of a breast cancer early detection program in Rwanda that was initially piloted in a single district. Specifically investigators will examine patient volume, service delivery, loss-to-follow-up rates, and cancer detection rates noted following implementation of scale-up to 3 additional districts. For scaleup, breast cancer screening with CBE was added to a cervical cancer screening initiative, in a combined Women's Cancer Early Detection Program (WCEDP).
Detailed description
Investigators previously conducted a cluster randomized controlled trial of a clinician training program to facilitate prompt evaluation of women with breast symptoms in one rural district of Rwanda. Subsequently, Rwanda Biomedical Centre (RBC) has scaled up the curriculum in 3 districts, adapting the program to integrate CBE screening into a cervical cancer screening initiative. In this study, we will evaluate implementation of this combined screening initiative. Investigators will assess patient volume, services, diagnoses, and loss to follow up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Early diagnosis program combined with electronic medical record | Implementation of early diagnosis approach targeting symptomatic women, combined with use of electronic medical record to facilitate documentation, patient tracking across levels of the health care system, and patient contact |
Timeline
- Start date
- 2020-07-01
- Primary completion
- 2021-12-31
- Completion
- 2022-03-25
- First posted
- 2020-02-06
- Last updated
- 2022-04-07
Locations
1 site across 1 country: Rwanda
Source: ClinicalTrials.gov record NCT04258085. Inclusion in this directory is not an endorsement.